BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12483875)

  • 1. [Spielmeyer-Vogt-Sjögren disease].
    Saitoh S
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):255-7. PubMed ID: 12483875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kufs' disease].
    Nagasato K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):258-61. PubMed ID: 12483876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Jansky-Bielschowsky disease].
    Saitoh S
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):252-4. PubMed ID: 12483874
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuronal ceroid lipofuscinosis/Batten disease: the lysosomal proteinoses.
    Gupta P; Hofmann SL
    Mol Psychiatry; 2002; 7(5):434-6. PubMed ID: 12082556
    [No Abstract]   [Full Text] [Related]  

  • 5. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
    Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic spectrum of human neuronal ceroid-lipofuscinoses.
    Mole SE
    Brain Pathol; 2004 Jan; 14(1):70-6. PubMed ID: 14997939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case 27-2002: late-onset infantile neuronal ceroid lipofuscinosis.
    McBride KL
    N Engl J Med; 2003 May; 348(21):2159. PubMed ID: 12761381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuronal ceroid lipofuscinosis (NCL, Batten's disease)].
    Ohno K
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):486-8. PubMed ID: 11032003
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Australasian diagnostic service for the neuronal ceroid lipofuscinoses.
    Muller VJ; Paton BC; Fietz MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():197-201. PubMed ID: 11588997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular genetic basis of the neuronal ceroid lipofuscinoses.
    Gardiner RM
    Neurol Sci; 2000; 21(3 Suppl):S15-9. PubMed ID: 11073223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ceroid lipofuscinoses: research update.
    Wisniewski KE; Kida E; Connell F; Zhong N
    Neurol Sci; 2000; 21(3 Suppl):S49-56. PubMed ID: 11073228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.
    Zhong N; Moroziewicz DN; Ju W; Jurkiewicz A; Johnston L; Wisniewski KE; Brown WT
    Genet Med; 2000; 2(6):312-8. PubMed ID: 11339651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
    Chattopadhyay S; Pearce DA
    Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays.
    Sohar I; Lin L; Lobel P
    Clin Chem; 2000 Jul; 46(7):1005-8. PubMed ID: 10894849
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2).
    Hofmann SL; Atashband A; Cho SK; Das AK; Gupta P; Lu JY
    Curr Mol Med; 2002 Aug; 2(5):423-37. PubMed ID: 12125808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles.
    Ju W; Zhong R; Moore S; Moroziewicz D; Currie JR; Parfrey P; Brown WT; Zhong N
    J Med Genet; 2002 Nov; 39(11):822-5. PubMed ID: 12414822
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuronal ceroid lipofuscinoses and possible pathogenic mechanism.
    Zhong N
    Mol Genet Metab; 2000; 71(1-2):195-206. PubMed ID: 11001811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
    Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
    Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses.
    Kohan R; Noher de Halac I; Tapia Anzolini V; Cismondi A; Oller Ramírez AM; Paschini Capra A; de Kremer RD
    Clin Biochem; 2005 May; 38(5):492-4. PubMed ID: 15820783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.